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1. Introduction 
 
The Parkinson’s disease (PD) was described by James Parkinson in 1817, like a “Shaking 
Palsy”. It is a progressive, degenerative disease of the basal ganglia. 
 
The basic biochemical cause of the Parkinson’s disease is the dopamine deficiency in the 
striatum and other basal ganglia, which is caused by the absence of the dopaminergic neuron 
cells in the substantia nigra pars compacta. 
 
The cardinal signs of PD are resting tremor, rigidity, bradykinesia / akinesia, and postural 
instability. Besides this, innumerable motor and non-motor signs can be present, which 




PD is a widespread disease, e.g. in USA the prevalence of around 100-250 /100 000, in  China 
1,7 /100 (95 % CI 1,5-1,9; age ≥65 y/o). The prevalence can be influenced by social and 




Actually the diagnosis of Parkinson’s disease is based on the medical history and on the 
neurologic physical examination. Frequently the early signs are slight; generally a close 
following of the patient is necessary before to say a defenitive diagnosis. 





o Stereotactic ablation: pallidotomy, thalamotomy, Subthalamic nucleus 
ablation 
o Subthalamic nucleus-, Thalamic nucleus ventral intermedius-, Globus 
pallidum pars interna- deep brain stimulation (DBS). 
• Procedures under investigation and evaluation 
 
5. Operative treatment 
 
Pharmacological treatment is the choice of treatment in Parkinson’s disease. However, in 
some special circumstances surgical intervention can also be employed, which we can explain 
with the following factors. 1/. Following a period of chronic administration, antiparkinsonian 
drugs become insufficient to control the progressive symptoms and signs of PD. 2/. 
Development of new neurosurgical and brain-imaging techniques, advances in precise 
neurophysiological monitoring have made surgical interventions safe and effective. 3/. 
Extensive studies of the anatomy and the pathophysiology of the basal ganglia and their 
association system, especially new observations made during experiments in primates with 1-
methyl-4-phenyl-1,2,3,6-tetrahydropiridin (MPTP) and the development of deep brain 
stimulation (DBS), have paved the way for novel therapeutic strategies and major advances in 
the field. In particular, the operative results have demonstrated major improvements in the 
quality of life of patients with PD. 
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In ideal conditions surgery will be recommended for the following patients: 
• Idiopathic Parkinson’s disease, 
• relatively young age (<70 years old), 
• with main parkinsonian symptoms initially responding to levodopa therapy, but 
gradually developing unresponsiveness for medical therapy, 
• Drug induced dyskinesia or rigidity, tremor, bradykinesia, march and postural 
instability, motor flctuation, 




1. Evaluation of the effects of ablative pallidotomy, pallidothalamotomy and STN-DBS 
neurostimulation procedures on the motor functions in Parkinson’s disease patients. 
2. Evaluation of the effects of STN-DBS neurostimulation on the cognitive functions in 
Parkinson’s disease patients. 
3. Evaluation of the effects of ablative pallidotomy, pallidothalamotomy and STN-DBS 
neurostimulation procedures on the time required for performing certain manual tasks 
in Parkinson’s disease patients. 
4. Measurement of certain brain metabolite ratio by using Proton Magnetic Resonance 
Spectroscopy (¹H-MRS) in Parkinson’s disease patients treated with STN-DBS. 
5. There might be some correlation between the clinical improvements and the changes 
of brain metabolite ratios occured after neurostimulations procedure. 
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7. Patient monitoring 
7.1. Motor function evaluation 
7.1.1. Fahn Tolosa Marin test 
The time required for different manual tasks to be performed (i.e. “performance time”) 
was compared before and after stereotactic surgery using the „B” part of Fahn-Tolosa-
Marin Tremor Rating scale. The performance time was measured in seconds by means 
of a chronometer. 
7.1.2. Unified Parkinson Disease Rating Scale – Motor Examination subscore – 
(UPDRS- part III) 
The UPDRS part III is apt for motor function examination (maximum 108 point): 
among other things we can evaluate the hand movements, tremor, walking, posture, 
speech, rigidity, etc. In normal case 4, and in severe cases 0 can be given. 
 
7.2. Cognitive function evaluation 
Neuropsychologic tests: 
 Mini Mental State Examination (MSE) 
 Auditory Verbal Learning (AVLT) 
 Raven test (PRM) 
 Bergen test (BRFT) 
 Montgomery-Asberg Depression Rating Scale (MADRS) 
 Hungarian Wechsler Intelligency Test (MAWI) 
 Verbal fluency 
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7.3. Proton magnetic resonance spectroscopy (¹H -MRS) 
 
Proton magnetic resonance spectroscopy (¹H -MRS) is a useful noninvasive method used to 
study central nervous system pathologies, and allows in vivo investigation of a number of 
cerebral metabolites such as N- acetylaspartate (NAA), choline (Cho), creatine (Cr), 
myoinositol (My), phosphocreatine (PCr) and lactate. Cho (altered neuronal membrane 
synthesis and degradation can result in changes in Choline) and Cr (a key energetic metabolite 
and, therefore, a possible indicator of defective energy metabolism) are present in all brain 
cells, whereas NAA has been localized in and is a putative marker of viable neurons and, 
therefore, a possible indicator of neuron loss. 
 
8. Patients and methods 
 
8.1. Effect of Pallidotomy and pallidothalamotomy on the motor function and the 
performance time 
Twenty-eight consecutive, right-handed patients with Parkinson's disease participated 
in the prospective study (mean age was 58,8 ± 3,53 years old; male 12, female 16; 
mean disease duration was 6,5 ± 4,5 years). Pallidotomy (mean age was 60,14 years; 
mean disease duration was 6,5 years) and combined pallidothalamotomy (mean age 
was 57,6 years; mean disease duration was 6,5 years) was performed in 10 and 18 
patients, respectively. On the basis of the presenting symptoms and signs, the patients 
were divided into two groups. 
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Group ”A” patients were characterized by presenting mainly hypo- or akinesia, 
rigidity, on/off fluctuation and L-dopa induced dyskinesia. 
 
Group ”B” patients were showing not only the symptoms and signs of Group „A” 
patients but also severe tremor. 
 
In patients of Group ”A” stereotactic pallidotomy was performed, and in patients of 
group ”B” pallidotomy was supplemented with stereotactic thalamotomy. 
 
For motor function examination the UPDRS part III and Fahn-Tolosa-Marin test were 
used. The evaluations were compared before the operation, and 2 days, 3 and 6 months 
postoperatively. 
 
8.2. Effect of the STN-DBS on the motor, cognitive functions and the performance time 
Thirteen (mean age was 59.37 ± 6.53 years old; male:9, female:4; mean disease 
duration was 15.415 ± 5.6 years) consecutive, right-handed patient with Parkinson's 
disease participated in the prospective study. 
 
The time required for different manual tasks to be performed was measured and the 
motor function evaluations were made while the patients were “on” (currently taking 
levodopa and others PD medications, clinically “on”) medication since most of them 
were unable to perform tasks under “off” (>12 hours off levodopa, and without others 
PD medications, clinically defined “off” ) medication. For motor function examination 
the UPDRS part III and Fahn-Tolosa-Marin test were used, and the cognitve function 
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was evaluated by a previously assembled neuropsychologic tests. These evaluations 
were perfomed before the operation, and 3 months postoperatively. 
 
8.3. ¹H- MR Spectroscopy assay 
Thirteen consecutive, right-handed patients (mean age was 59.3 ± 6.5 years old; 
male:9, female:4; mean disease duration was 15.4 ± 5.6 years) with Parkinson's 
disease participated in the prospective study. 
 
All patients underwent single-voxel ¹H -MRS of the Gp and the FBC, using a single 
voxel system implemented on a 1 tesla scanner (Siemens). A short TE stimulated echo 
acquisition mode (STEAM) technique (TR = 2000 ms, TE = 30 ms, TM = 10 ms, 128 
scans accumulated for signal averaging, volume of interest (VOI) dimension = 
20x20x20 mm, water suppression 35 Hz, acquisition duration = 853 ms) was 
employed. The VOI was centered on the left and right Gp, and on the FBC. NAA/Cho, 
NAA/Cr, and Cho/Cr ratios were obtained. 
 
The ¹H-MRS results (NAA/Cho, NAA/Cr, and Cho/Cr ratios) were compared before 
the operation (patients were in the "off state"), and 3 months postoperatively 
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9.1. Effect of Pallidotomy and Pallidothalamotomy on the motor function and the 
performance time 
Pallidotomy 
The following results were obtained after pallidotomy by using the UPDRS part III. :  
“On state” preoperative mean was 51,2 pts, at 2nd day postoperative 29,5, at 3rd and 6th 
month 26,0. “Off state” preoperative mean was 64,3 pts, at 2nd day postoperative 31,6, 
at 3rd and 6th month 26,0 pts. 
 
1) During the drawing of large and small Archimedes spiral (task A & B), mean 
performance times preoperatively, and 2 days, 3 months and 6 months postoperatively 
were as follows: 42,7 s, 17,0 s, 15,3 s, and 13,0 s respectively.  
2) The analogous data in task C were 18,7 s, 5,8 s, 5,8 s. and 4,3 s.  
3) The handwriting performance times at the same timepoints were 22,7 s, 15,0 s, 
14,7 s, and 10,6 s. 
 
In all four evaluated qualities (i.e. task A, B, C and handwriting) the performance 
times improved singnificantly (p<0,0001).. 
 
Combined pallidothalamotomy 
The following results were obtained by using the UPDRS III.: “On state” preoperative 
mean was 43,5 pts, at 2nd day postoperatively 27,9, at 3rd month 22,9, at 6th month 22,8 
pts. “Off state” preoperative mean was 62,6, at 2nd day postoperatively 38, at 3rd 
month 30, at 6th month 31,8 pts. 
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1) In tasks A & B, the respective times were as follows: 16,7 s, 12,6 s, 13,6 s and 13,8 
s.  2) In task C, the times were: 22,5 s, 14,0 s, 14,0 s and 15,0 s.  3) The following 
results were obtained for the handwriting performance times: 25,9 s, 20,4 s, 21,3 s 
and 22,5 s. 
 
In all four evaluated qualities (i.e. tasks A, B, C and handwriting) the performance 
times improved significantly (Student ”t”-tests, p<0,001). 
 
9.2. Effect of the STN-DBS on the motor, cognitive function and the performance time 
The following results were obtained by measuring the performance times and motor 
(UPDRS – III) function: 
1. “On” state: during the drawing of the large Archimedes spiral (task A), mean 
performance times preoperatively (on medication), and 3 months (on medication/on 
DBS) postoperatively were 15,3 s and 8,9 s, respectively. For the small Archimedes 
spiral (task B), the corresponding data were 18,5 s and 10,6 s. The analogous data in 
task C were 9,0 s and 3,9 s. 
2. “Off” state: during the drawing of the large Archimedes spiral (task A), mean 
performance times preoperatively (off medication), and 3 months (off medication/on 
DBS) postoperatively were 28,0 s and 8,3 s, respectively. For the small Archimedes 
spiral (task B), the corresponding data were 30,1 s and 10,8 s. The analogous data in 
task C were 24,6 s and 3,7 s. 
3. The handwriting performance times at the same timepoints were: “on” state - (on 
medication) 32,7 s, and (on medication/on DBS) 17,8 s;  “off” state - (off medication) 
66,0 s, and (off medication/on DBS) 16,9 s. 
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In all four evaluated qualities (i.e. task A, B, C and handwriting) the performance times 
improved significantly (Student ”t”- test, p<0.1). 
 
The following results were obtained after DBS of the STN implantation by using the 
UPDRS part III.: “On state” preoperative mean (on medication) 57,2/108 pts, at 3rd month 
(on medication/on DBS) 12,6 pts. “Off state” preoperative mean (off medication) 73,5/108 
pts, at 3rd month (off medication/on DBS) 22,5 pts. All results obtained during “off 
medication/off DBS” state evaluation were close to the preoperative “off” state. 
 
The difference obtained in motor function by using UPDRS – III was significant (Student 
”t”-test, ”on phase” p=3.0E-07, ”off phase” p<0.01 ) 
 
The results obtained by using the neuropsychologic tests for the cognitive function 
evaluation are showing on the table # 2. During the evaluation of the cognitive function 
only the AVLT showed significant improvement. 
 
9.3. ¹H- MR Spectroscopy experiment 
The following results were obtained from ¹H-MRS measures: significant increases of 
the NAA/Cho (stud. “t”: 0.046) and NAA/Cr (stud. “t”: 0.032), and significant 
decreases of the Cho/Cr (stud. “t”: 0.036) ratios were observed from the selected voxel 
in the left FBC. In all patients, decreases in NAA/Cho ratios were observed from the 
selected voxels in left and right Gp, however these changes were not significant. 
 
The following results were obtained after DBS of the STN implantation by using the 
UPDRS part III: “On state” preoperative mean (on medication) was 57,2/108 pts, at 3rd 
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month (on medication/on DBS) 12,6 pts; Stud. “t” p=3.08346E-07. “Off state” 
preoperative mean (off medication) was 73,5/108 pts, at 3rd month (off medication/on 
DBS) 22,5 pts; Stud. “t” p<0.01. All results obtained during “off medication/off DBS 




1. Effect of Pallidotomy and pallidothalamotomy on the motor function and the 
performance time 
No complications developed following pallidotomy. 
Pallido-thalamotomy caused transient adverse effects in 2 patients, and 1 patient 
developed permanent adverse effects such as dysarthria and loss of balance. 
2. Effect of the STN-DBS on the motor, cognitive function and the performance 
time 
One patient died postoperatively (4 months) after an intracerebral hemorrhage, and 
one patient who was treated surgically, developed wound seroma around IPG (impulse 
generator); his IPG was removed and implanted four weeks after on the other side 
without complications 
3. ¹H-MR Spectroscopy 
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Pallidotomy does not suppress tremor to such a significant degree as thalamotomy does. 
Therefore, the introduction of a combined procedure (Gip and Vim ablation) was logical. 
Based on many bibliographical data, combined surgical interventions (pallido-thalamotomy) 
alleviate not only the hyperkinetic (tremor) but also the hypokinetic symptoms such as 
rigidity, bradykinesia, march and postural instability. Pallidotomy (Gpi) can improve the 
executory movements (movement tasks), such as pronation, supination and agility of the 
hands and fingers (dexterity), as well as movements of the arm. The hand becomes more 
punctual and subtle. These are appreciated in lesser degree in the ipsilateral side than in the 
contralateral side. 
 
Thalamotomy primarily is apt for tremor attenuation. Ablative intervention in the thalamus 
(Vim) can be effective not only in suppressing the tremor, but also in increasing and 
improving the agility of the hand-movements. 
 
The effects of the stereotactic procedures were evaluated by certain parts of the Fahn–Tolosa-
Marín Tremor Rating Scale. The performance time was measured before the operation, and 2 
days, 3 and 6 months postoperatively. 
 
We came to the conclusion that pallidotomy diminished the manual task performance time 
significantly. The additional therapeutic effects such as acceleration and improvement of 
subtlety of the hand movements can be ascribed to the suppression or relief of the rigidity and 
hypokinesia also brought about by the operation. The decrease of the perfomance time 
observed in the course of observation, may be due to movement therapy applied after the 
surgical procedure. 
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The decrease of the performance time observed after combined pallidothalamotomy 
procedures was not significant such as after pallidotomy. This phenomenon can be explained 
with the following fact, that the combined procedures were used mostly in Parkinson’s 
disease patients with severe clinical symptoms, in whose besides for the pallidotomy 
indications tremor was also a characteristic sign. Furthermore, Parkinson’s tremor is mainly 
resting in quality and doesn’t intensify to action, hereby this kind of tremor may have less 
influence on the performance time. 
 
There has been little data published concerning the speed of performance in handwriting and 
drawing following STN-DBS implantation.  In this prospective study, the performance times - 
measured preoperatively and at 3 months postoperatively - clearly revealed that STN-DBS 
diminished the performance time for manual tasks, and improved motor scores (UPDRS III, 
specially finger tapping, hand pronation – supination, hand opening – closing) significantly, 
showing that might be a partial restoration of an “open-loop” automatic performance. Effects 
of the STN-DBS on the acceleration of performance time are not exactly known, but seems to 
be ascribed to the suppression or relief of symptoms brought about by the operation.  These 
improvements may strongly be correlated with improvements in motor function (UPDRS III), 
primarily with regard to bradykinesia, and in particular with improvements of the sequential 
hand movements (finger tapping, hand pronation – supination, hand opening – closing). 
 
The evidence of motor score improvement after STN-DBS is in concordance with the 
findings of other authors. These authors described motor score improvements in UPDRS III. 
Our observations indicate that STN-DBS improves not only motor scores (UPDRS III), but 
significantly diminishes the time required for certain manual performances, as well. We have 
                                                                                                                                                     Llumiguano C. 16
reported similar improvements after ablative procedures (pallidotomy and pallido-/, 
thalamotomy). 
 
Our observations indicate that stereotactic surgery for patients with Parkinson’s disease 
improves not only motor function, but significantly diminishes the time required for certain 
manual performances, as well. 
 
To our knowledge, this is the first study applying a parallel evaluation of ¹H-MRS results and 
clinical improvement in Parkinson’s disease patients following STN-DBS. Using this 
technique, we have demonstrated that cortical (LFBC) NAA/Cho and NAA/Cr ratios were 
significantly increased; paired with a significant decrease of Cho/Cr ratio in all patients 
treated with STN-DBS. An insignificant decrease of the NAA/Cho ratio was observed in the 
selected voxels in Gp. 
 
The underlying mechanism that might influence the observed concentration changes of the 
metabolites after STN-DBS is not elucidated yet. We consider that DBS may possibly 
increase the metabolism of neurons, or a sort of way can restore the function of a damaged 
neuron cells. Clinically these are showing in motor and cognitive function improvement. 
 
Besides the metabolic changes, significant motor score improvements were observed 
(UPDRS III) 3 months following STN-DBS procedure, and these improvements were also 
highly correlated with amelioration in motor function, primarily regarding bradykinesia. After 
3 months of the STN-DBS procedures during the cognitive function evaluation, just the 
AVLT improvements were significant; and the results of the other applied neuropsychologic 
tests were not significantly different. The deterioration of the cognitive function firstly can be 
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due to the disorder of the motor function, and to the decrease of the capacity of visuospatial 
orientation, in other way may be a consequense of the advanced age of life, and the frontal, 
parietal, and occipital cortical dysfunction. Taking bibliographic data into account, we 
suppose that the significant improvement of the AVLT may be explained with the motor 
function improvements occured after STN-DBS, and possibly herewith linear concentration- 
and visuospatial orientation capacity improvements. 
 
This study is still in progress and the number of patients is too small for any definite 
considerations. However our results suggest that NAA/Cho and NAA/Crea ratios may be a 
valuable criterion for evaluation of Parkinson’s disease patients with the clinical improvement 
following STN-DBS. ¹H-MRS may be a useful utility as an aid in better understanding the 
pathophysiological process in Parkinson’s disease patients on the basis of the variation of 
NAA/Cho and NAA/Crea ratios, and may be regarded as an useful technique to monitor 
disease progression. This data also suggests that NAA/Cho and NAA/Cr ratios could be a 
measure of functional impairment of cortical neurons in PD, but to certify these more studies 
are needed. 
 
12. New results 
1. We demostrate that pallidotomy diminished the manual task performance time 
significantly. 
 
2. After combined pallidothalamotomy the decrease of the manual performance time was 
not significant such us after pallidotomy. 
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3. We demostrate that STN-DBS diminished significantly the performance time for 
manual tasks, and improved motor scores (UPDRS III, specially finger tapping, hand 
pronation – supination, hand opening – closing) significantly. 
 
4. Our observations have indicated that stereotactic surgery for patients with Parkinson’s 
disease improves not only motor function, but significantly diminishes the time 
required for certain manual performances, as well. 
 
5. To our knowledge, this is the first study applying a parallel evaluation of ¹H-MRS 
results and clinical improvement in Parkinson’s disease patients following STN-DBS. 
 
6. Using ¹H-MRS, we have demonstrated that cortical (LFBC) NAA/Cho and NAA/Cr 
ratios were significantly increased; paired with the significant decrease of Cho/Cr ratio 
in all patients treated with STN-DBS. 
 
7. Using ¹H-MRS, we observed that the decrease of the NAA/Cho ratio in the selected 
voxels in Gp was insignificant. 
 
8. We demostrate, that besides the metabolic changes, significant motor score 
improvements were observed (UPDRS III) 3 months following STN-DBS procedure, 
and these improvements were also highly correlated with amelioration in motor 
function, primarily regarding bradykinesia. 
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9. After 3 months of the STN-DBS procedures during the cognitive function evaluation, 
just the AVLT improvements were significant. and the results of the other applied 
neuropsychologic tests were not significantly different. 
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